Pancreatic Cancer Research

ResearcherFudan UniversityActive in the last 2 years

Yi Zhun Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7700-8041; OpenAlex author ID A5088412895. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 3 papers

Papers 4

  1. Vision transformer network discovers the prognostic value of pancreatic cancer pathology sections via interpretable risk scores. Co-author DOI 10.1007/s12672-025-03547-3↗
  2. DDR1 Drives Collagen Remodeling and Immune Exclusion: Pan-Cancer Insights and Therapeutic Targeting in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms26167731↗
  3. Human multiethnic radiogenomics reveals low-abundancy microRNA signature in plasma-derived extracellular vesicles for early diagnosis and molecular subtyping o… Co-author DOI 10.7554/elife.103737↗
  4. The JNK Signaling Pathway Is a Novel Molecular Target for S-Propargyl- L-Cysteine, a Naturally-Occurring Garlic Derivatives: Link to Its Anticancer Activity in… Last author DOI 10.2174/1568009615666150602143943↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maciej Pech · 2 shared papers, 2025 · strength 0.45
  2. Wenjie Shi · 2 shared papers, 2025 · strength 0.45
  3. Ulf D. Kahlert · 2 shared papers, 2025 · strength 0.45
  4. Li Ye · 1 shared paper, 2025 · strength 0.24
  5. Xuan Huang · 1 shared paper, 2025 · strength 0.24
  6. Wei Chen · 1 shared paper, 2025 · strength 0.24
  7. Zhiyong Peng · 1 shared paper, 2025 · strength 0.23
  8. Ujjwal Mukund Mahajan · 1 shared paper, 2025 · strength 0.22
  9. Christoph Kahlert · 1 shared paper, 2025 · strength 0.22
  10. Wei Wang · 1 shared paper, 2015 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.